Q1 Earnings Estimate for Vaxcyte Issued By Leerink Partnrs

Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) – Equities researchers at Leerink Partnrs issued their Q1 2025 EPS estimates for shares of Vaxcyte in a research report issued on Tuesday, February 25th. Leerink Partnrs analyst D. Risinger anticipates that the company will earn ($1.01) per share for the quarter. The consensus estimate for Vaxcyte’s current full-year […]

Leave a Reply

Your email address will not be published.

Previous post ZoomInfo Technologies (NASDAQ:ZI) Price Target Raised to $14.00
Next post Editorial: D.C. shouldn’t make life harder for military spouses